Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Sandler

Showing results (301-310 of 321) with videos related to

Pageof 33
Sort By:
JSES Reviews, Reports, and Techniques|October 30, 2024
High rates of return to sport after suprascapular nerve decompression: an updated systematic reviewAlexis B Sandler, Matthew E Wells, Calvin Tran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancerA B Sandler, J Nemunaitis, C Denham, et al.
International Journal of Oncology|May 6, 2011
HPLC determination of serum levels of soluble p53 antigen as a new method for colon cancer detection, and its clinical implicationI Zusman, R Zusman, B Sandler, et al.
International Journal of Molecular Sciences|April 25, 2020
Obesity-Altered Adipose Stem Cells Promote Radiation Resistance of Estrogen Receptor Positive Breast Cancer through Paracrine SignalingRachel A Sabol, Vidal A Villela, Alexandra Denys, et al.
Cancer Chemotherapy and Pharmacology|May 21, 2005
Safety and pharmacokinetic study of RPI.4610 (ANGIOZYME), an anti-VEGFR-1 ribozyme, in combination with carboplatin and paclitaxel in patients with advanced solid tumorsHiroyuki Kobayashi, S Gail Eckhardt, Jennifer A Lockridge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2007
Phase II clinical trial of the epothilone B analog, ixabepilone, in patients with non small-cell lung cancer whose tumors have failed first-line platinum-based chemotherapyJohan Vansteenkiste, Primo N Lara, Thierry Le Chevalier, et al.
Cellular and Molecular Life Sciences : CMLS|January 27, 2023
LYST deficiency impairs autophagic lysosome reformation in neurons and alters lysosome number and sizeJenny Serra-Vinardell, Maxwell B Sandler, Raffaella De Pace, et al.
Cellular and Molecular Life Sciences : CMLS|March 4, 2023
Correction: LYST deficiency impairs autophagic lysosome reformation in neurons and alters lysosome number and sizeJenny Serra-Vinardell, Maxwell B Sandler, Raffaella De Pace, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2006
Processes to activate phase III clinical trials in a Cooperative Oncology Group: the Case of Cancer and Leukemia Group BDavid M Dilts, Alan B Sandler, Matthew Baker, et al.
Pediatric Blood & Cancer|June 22, 2023
NCI intramural program approach to rare tumors: Natural history study of rare solid tumors in children and adults: A longitudinal, comprehensive data and biospecimen collection protocolMary Frances Wedekind, Karlyne M Reilly, Jaydira Del Rivero, et al.
Pageof 33

Showing results (301-310 of 321) with videos related to

Sort By:
Pageof 33
JSES Reviews, Reports, and Techniques|October 30, 2024
High rates of return to sport after suprascapular nerve decompression: an updated systematic reviewAlexis B Sandler, Matthew E Wells, Calvin Tran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancerA B Sandler, J Nemunaitis, C Denham, et al.
International Journal of Oncology|May 6, 2011
HPLC determination of serum levels of soluble p53 antigen as a new method for colon cancer detection, and its clinical implicationI Zusman, R Zusman, B Sandler, et al.
International Journal of Molecular Sciences|April 25, 2020
Obesity-Altered Adipose Stem Cells Promote Radiation Resistance of Estrogen Receptor Positive Breast Cancer through Paracrine SignalingRachel A Sabol, Vidal A Villela, Alexandra Denys, et al.
Cancer Chemotherapy and Pharmacology|May 21, 2005
Safety and pharmacokinetic study of RPI.4610 (ANGIOZYME), an anti-VEGFR-1 ribozyme, in combination with carboplatin and paclitaxel in patients with advanced solid tumorsHiroyuki Kobayashi, S Gail Eckhardt, Jennifer A Lockridge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2007
Phase II clinical trial of the epothilone B analog, ixabepilone, in patients with non small-cell lung cancer whose tumors have failed first-line platinum-based chemotherapyJohan Vansteenkiste, Primo N Lara, Thierry Le Chevalier, et al.
Cellular and Molecular Life Sciences : CMLS|January 27, 2023
LYST deficiency impairs autophagic lysosome reformation in neurons and alters lysosome number and sizeJenny Serra-Vinardell, Maxwell B Sandler, Raffaella De Pace, et al.
Cellular and Molecular Life Sciences : CMLS|March 4, 2023
Correction: LYST deficiency impairs autophagic lysosome reformation in neurons and alters lysosome number and sizeJenny Serra-Vinardell, Maxwell B Sandler, Raffaella De Pace, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2006
Processes to activate phase III clinical trials in a Cooperative Oncology Group: the Case of Cancer and Leukemia Group BDavid M Dilts, Alan B Sandler, Matthew Baker, et al.
Pediatric Blood & Cancer|June 22, 2023
NCI intramural program approach to rare tumors: Natural history study of rare solid tumors in children and adults: A longitudinal, comprehensive data and biospecimen collection protocolMary Frances Wedekind, Karlyne M Reilly, Jaydira Del Rivero, et al.
Pageof 33